BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20408337)

  • 21. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
    Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
    Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system.
    Jaber BL; Perianayagam MC; Balakrishnan VS; King AJ; Pereira BJ
    J Leukoc Biol; 2001 Jun; 69(6):1006-12. PubMed ID: 11404388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriages.
    Kaponis A; Skyrlas A; Zagorianakou N; Georgiou I; Passa V; Paraskevaidis E; Makrydimas G
    Hum Reprod; 2008 May; 23(5):1159-69. PubMed ID: 18316328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis and cell death in the endocrine system.
    Mountz JD; Zhang HG; Hsu HC; Fleck M; Wu J; al-Maini MH; Zhou T
    Recent Prog Horm Res; 1999; 54():235-68; discussion 269. PubMed ID: 10548879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC
    Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
    Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited expression of Fas and Fas ligand in fetal nucleated erythrocytes isolated from first trimester maternal blood.
    Sohda S; Samura O; Johnson KL; Falco VM; Elmes RS; Bianchi DW
    Prenat Diagn; 2002 Dec; 22(13):1213-8. PubMed ID: 12478636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
    Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
    J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
    Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
    Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells.
    Jiang S; Wu MW; Sternberg P; Jones DP
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):645-55. PubMed ID: 10711676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure.
    Kuhla A; Eipel C; Siebert N; Abshagen K; Menger MD; Vollmar B
    Apoptosis; 2008 Dec; 13(12):1427-38. PubMed ID: 18946736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune lymphoproliferative syndrome in a patient with common variable immunodeficiency: dichotomy of apoptosis.
    Narra MB; Abdou NI
    Ann Allergy Asthma Immunol; 2007 Jun; 98(6):585-8. PubMed ID: 17601274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome.
    Nabhani S; Hönscheid A; Oommen PT; Fleckenstein B; Schaper J; Kuhlen M; Laws HJ; Borkhardt A; Fischer U
    Clin Immunol; 2014 Dec; 155(2):231-7. PubMed ID: 25451160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
    Bi LL; Pan G; Atkinson TP; Zheng L; Dale JK; Makris C; Reddy V; McDonald JM; Siegel RM; Puck JM; Lenardo MJ; Straus SE
    BMC Med Genet; 2007 Jul; 8():41. PubMed ID: 17605793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Marzano AV; Frezzolini A; Caproni M; Parodi A; Fanoni D; Quaglino P; Girgenti V; La Placa M; Fabbri P; Caputo R; Berti E
    Int J Immunopathol Pharmacol; 2007; 20(3):557-66. PubMed ID: 17880768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).
    Marega LF; Teocchi MA; Dos Santos Vilela MM
    Clin Exp Immunol; 2016 Aug; 185(2):148-53. PubMed ID: 27060458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.